|
World
Cancer Congress
|
A closer look at landmark trials and how they are
changing the medical landscape.
|
|
|
Baby Minder Out Now
PhP 75 Each
All New Growing
Kids
PhP 95 Each
Sold at your
nearest
National
Bookstores
|
The heart of the matter
INVEST, GALAXY, CHARM, and many
others—how do we sift through the medical evidence on
the best ways to fight heart disease and related problems? Grace Roxas
looks at the data, and talks to experts on how these apply in the Philippine
setting. [More]
Sweeter by the thousands
Dr. Chiles Samaniego goes
through the many studies involving diabetes treatment options—and tries to
figure out how best to apply their results to Filipino patients. [More]
Survival of the fittest
Which agent works best for which
malignancy, and which patient group, and which cancer stage? Dr. Roger
Badillo looks at how the large-scale clinical trials are changing the ways
we treat cancer patients. [More]
|
Ninety-five, 76, 49, and tens of thousands—her
birthday, her years in the profession, the years since she founded her beloved
hospital, and the number of people whose lives she has touched. MEDICAL OBSERVER
honors the physician, Dr. Fe del Mundo.
[More]
|
Clinical implications of genetic
polymorphism
Gastroenterology. Dr. Irma Makalinao that genetic issues may
have a significant effect on treatment with proton-pump inhibitors. [More]
A multidisciplinary approach to
gliomas
Oncology. A group of doctors show that a multidisciplinary approach
to the management of malignant gliomas, together with treatment with
temozolomide, raises survival rates. [More]
Imatinib gold standard for treatment
of CML
Oncology. The
“designer drug” imatinib has been considered the gold standard for the treatment
of chronic myelogenous leukemia. [More]
Preventing HPV infection, cancer,
warts and all
Oncology. Vaccination may finally be the solution to finally wipe out
infection with the human papillomavirus, as well as the dreaded cervical cancer. [More]
|
